PON2 and cancer: While antioxidative and antiatherogenic [36,37] effects triggered by PON2 have been extensively elucidated and consolidated, data demonstrating its involvement in molecular processes that negatively influence programmed cancer cell death by inhibiting the intrinsic apoptotic pathway were recently reported following in vitro studies carried out in immortalized human vascular endothelial EA.hy 926 cells [32].